Published in J Immunol on March 01, 1979
Effect of interleukin 1 on human thymocytes and purified human T cells. J Exp Med (1981) 1.50
Human endothelial cell-lymphocyte interaction. Endothelial cells function as accessory cells necessary for mitogen-induced human T lymphocyte activation in vitro. J Clin Invest (1981) 1.31
Evidence for an interleukin-independent pathway for human lymphocyte activation. Proc Natl Acad Sci U S A (1983) 1.10
Human erythroid burst-forming units. Growth in vitro is dependent on monocytes, but not T lymphocytes. J Clin Invest (1981) 1.07
Effects of cyclosporin A on the metabolism of unstimulated and mitogen-activated lymphocytes. Immunology (1983) 0.99
Interaction of pokeweed mitogen with monocytes in the activation of human lymphocytes. Immunology (1983) 0.98
Functional characteristics of human T-cell subpopulations distinguished by a monoclonal antibody. Proc Natl Acad Sci U S A (1980) 0.97
Pokeweed-mitogen induced lymphocyte proliferation: the effect of stimulation on mononuclear phagocytic cells. Immunology (1980) 0.94
Role of interleukin-2 and interleukin-6 in the mitogen responsiveness of T cells from patients with 'common-variable' hypogammaglobulinaemia. Clin Exp Immunol (1990) 0.93
Characteristics of human monocytes cultured in the Teflon culture bag. Immunology (1982) 0.93
Activation requirements and responses to TLR ligands in human CD4+ T cells: comparison of two T cell isolation techniques. J Immunol Methods (2009) 0.92
Activation of human monocytes for nitroblue tetrazolium reduction and the suppression of lymphocyte response to mitogens. Clin Exp Immunol (1980) 0.89
Amplification of the polyclonal activation of human T cells. I. Null-cell products promote the polyclonal proliferation of T cells. Immunology (1982) 0.89
Inhibitory versus stimulatory effects of natural human interferon-alpha on proliferation of lymphocyte subpopulations. Immunology (1992) 0.89
Regulation of human B cell activation by prostaglandin E2. Suppression of the generation of immunoglobulin-secreting cells. J Clin Invest (1985) 0.86
Bovine monocytes and macrophages: an accessory role in suppressor-cell generation by Con A and in lectin-induced proliferation. Immunology (1983) 0.86
Phytohaemagglutinin-induced proliferation of human T lymphocytes: differences between neonate and adults in accessory cell requirements. Clin Exp Immunol (1983) 0.84
Regulatory effect of monocytes on T cell proliferative responses to oral microbial antigens. Infect Immun (1982) 0.83
In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferation. Immunology (1982) 0.83
T-cell growth factor-mediated proliferation of lymphocytes from a T-chronic lymphocytic leukaemia patient lacking mitogen and alloantigen responsiveness. Clin Exp Immunol (1981) 0.81
Isolation of human monocytes by rosetting with antibody coated human erythrocytes and isopycnic gradient centrifugation. Clin Exp Immunol (1982) 0.80
Monocytes are required to trigger Ca2+ uptake in the proliferative response of human t lymphocytes to staphylococcus aureus protein A. Proc Natl Acad Sci U S A (1984) 0.80
An in vitro model for the induction of angiotensin-converting enzyme in sarcoidosis: possible parallels to the immune response. Clin Exp Immunol (1988) 0.80
Neutralization of mitogenic lectins by intravenous immunoglobulin (IVIg) prevents T cell activation: does IVIg really have a direct effect on T cells? Clin Exp Immunol (2011) 0.79
Development of a chemically defined serum- and protein-free medium for growth of human peripheral lymphocytes. Proc Natl Acad Sci U S A (1986) 0.78
Cell-mediated responses of immunized vervet monkeys to defined Leishmania T-cell epitopes. Infect Immun (1994) 0.77
Genetic Mapping of Novel Loci Affecting Canine Blood Phenotypes. PLoS One (2015) 0.76
Antigen-dependent and -independent proliferative T-cell populations in the peritoneal exudate cells of immunized mice. Immunology (1989) 0.75
Direct TLR-2 Costimulation Unmasks the Proinflammatory Potential of Neonatal CD4+ T Cells. J Immunol (2016) 0.75
The lack of effect of histamine--protein conjugates on human lymphocyte responses to concanavalin A and histamine. Immunology (1983) 0.75
Measurement of single-cell DNA synthesis by pokeweed mitogen-stimulated mononuclear cells with combined light and scanning electron microscopy. Immunology (1986) 0.75
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med (1991) 16.81
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 16.28
Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci U S A (1983) 5.00
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol (1996) 4.99
Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A (1993) 4.45
Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet (1994) 3.45
Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res (1998) 3.39
Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol (1993) 3.36
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med (1996) 3.30
Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today (1994) 3.25
Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin Cancer Res (1995) 3.20
Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol (1993) 3.14
Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol Biol Med (1983) 3.04
Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med (1998) 3.01
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin Cancer Res (2000) 2.96
Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J Immunol (1988) 2.95
The rapid induction by phytohemagglutinin of increased alpha-aminoisobutyric acid uptake by lymphocytes. J Clin Invest (1971) 2.94
Interleukin-10. Curr Opin Immunol (1992) 2.85
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med (1994) 2.70
Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen. J Immunol (1985) 2.70
IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol (1992) 2.67
A novel receptor involved in T-cell activation. Nature (1995) 2.56
Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. Blood (1990) 2.48
B cell growth-promoting activity of recombinant human interleukin 4. J Immunol (1987) 2.31
Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J Exp Med (1991) 2.27
Sleep and behavior problems in school-aged children. Pediatrics (2001) 2.23
Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ (1996) 2.18
Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res (1984) 2.17
Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J Clin Oncol (2000) 2.13
Recombinant interleukin 4 promotes the growth of human T cells. J Immunol (1987) 2.13
Isolation and properties of polyribosomes and fragments of the endoplasmic reticulum from rat liver. Biochem J (1967) 2.13
Structure and expression of germline epsilon transcripts in human B cells induced by interleukin 4 to switch to IgE production. J Exp Med (1990) 2.09
Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J Immunol (1991) 2.07
Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase. J Biol Chem (1998) 2.06
Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts. Cancer Res (1993) 2.03
[Interval appendectomy as indicated rather than as routine therapy: fewer operations and shorter hospital stays]. Ned Tijdschr Geneeskd (2007) 1.98
Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity (1997) 1.97
Blockage of EGF receptor signal transduction causes reversible arrest of normal and immortal human mammary epithelial cells with synchronous reentry into the cell cycle. Exp Cell Res (1993) 1.84
Isolation of functionally different human monocytes by counterflow centrifugation elutriation. Blood (1982) 1.83
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. Semin Oncol (1999) 1.82
Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells. Clin Cancer Res (2000) 1.82
Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol (1998) 1.81
Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med (1996) 1.80
Characterization of monoclonal antibodies against cell surface molecules associated with cytotoxic activity of natural and activated killer cells and cloned CTL lines. Hybridoma (1983) 1.79
Host-reactive CD4+ and CD8+ T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-gamma and granulocyte/macrophage-colony-stimulating factor but not IL-4. J Immunol (1990) 1.79
Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion (1997) 1.75
Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation. Proc Natl Acad Sci U S A (1986) 1.72
Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res (1993) 1.70
Alpha-interferon treatment of patient with hyper IgE syndrome. Lancet (1989) 1.70
Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells. J Biol Chem (1994) 1.69
Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma. J Immunol (1988) 1.67
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. Clin Cancer Res (1999) 1.66
Antibodies and antigen expression in human melanoma detected by the immune adherence test. Int J Cancer (1975) 1.65
Expression of epidermal growth factor receptor and human papillomavirus E6/E7 proteins in cervical carcinoma cells. J Natl Cancer Inst (1997) 1.63
IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int Immunol (1993) 1.62
Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest (1995) 1.61
Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. Cancer Res (1986) 1.60
Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst (1993) 1.56
Relation of epidermal growth factor receptor concentration to growth of human epidermoid carcinoma A431 cells. J Biol Chem (1984) 1.55
Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145. Cancer Res (1996) 1.54
Transforming growth factor-beta directs IgA switching in human B cells. J Immunol (1992) 1.53
IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol (1992) 1.51
Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly. J Biol Chem (1991) 1.48
Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells. J Biol Chem (1998) 1.48
The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J Exp Med (1993) 1.41
Interleukin-4 mediates CD8 induction on human CD4+ T-cell clones. Nature (1988) 1.41
A centrifugal elutriation system of separating small numbers of cells. J Immunol Methods (1984) 1.40
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol (2004) 1.39
IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. J Immunol (1988) 1.38
Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. Clin Cancer Res (2001) 1.37
Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J Exp Med (1997) 1.37
Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J Immunol (1997) 1.37
Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. J Immunol (1999) 1.35
Properties of a panel of monoclonal antibodies which react with the human T cell antigen receptor on the leukemic line HPB-ALL and a subset of normal peripheral blood T lymphocytes. J Immunol (1986) 1.35
Alloantigen recognition is preceded by nonspecific adhesion of cytotoxic T cells and target cells. Science (1986) 1.34
Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells. Mol Cell Biol (1991) 1.32
Regulation of cyclooxygenase-2 pathway by HER2 receptor. Oncogene (1999) 1.31
Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity. Br J Cancer (2000) 1.31
Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol (1991) 1.30
Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes. J Clin Invest (1976) 1.29
Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. J Immunol (1984) 1.29
Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function. J Biol Chem (2000) 1.29
Electron microscopic observation on polyribosomes and endoplasmic reticulum fragments isolated from rat liver. Lab Invest (1966) 1.29
Natural killer cell clones can efficiently process and present protein antigens. J Immunol (1991) 1.28
RNA in nascent DNA from cultured human lymphocytes. Nat New Biol (1973) 1.28
Epitope mapping of recombinant human gamma interferon using monoclonal antibodies. Mol Immunol (1989) 1.27
Inhibition of human natural cytotoxicity by macromolecular antiproteases. J Immunol (1981) 1.27
Modulation of IL-4-induced human IgE production in vitro by IFN-gamma and IL-5: the role of soluble CD23 (s-CD23). J Cell Biochem (1989) 1.26
Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse. J Immunol (1991) 1.26
Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy. Int Immunol (1991) 1.24
Modulation of IL-4 induced germline epsilon RNA synthesis in human B cells by tumor necrosis factor-alpha, anti-CD40 monoclonal antibodies or transforming growth factor-beta correlates with levels of IgE production. Int Immunol (1992) 1.23
Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J Cell Biol (1995) 1.23
PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin Cancer Res (1997) 1.23
Epidermal growth factor-induced growth inhibition requires Stat1 activation. Cell Growth Differ (1998) 1.22